6505--Pylarify (piflufolastat F18) injections for Portland VA Health Care System

Award Notice Posted

Solicitation number
36C26025AP1501
Agency
Awarded
to Progenics Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36F79725D009336C26025F0276 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 has awarded a contract to Progenics Pharmaceuticals Inc. for Pylarify (piflufolastat F18) injections for the Portland VA Health Care System. The contract, numbered 36F79725D0093 36C26025F0276, is valued at $721,744.00 and will cover 115 BT's of the radioactive diagnostic agent used for PET imaging in men with prostate cancer. The contract is effective from July 1, 2025 to June 30, 2026, and was processed through the Vancouver, Washington contracting office. Progenics Pharmaceuticals is identified as the sole manufacturer of PYLARIFY, which justified the limited source procurement under Federal Acquisition Regulation 8.405-6(a)(1)(B).

Notice text

Awarded contract 36F79725D009336C26025F0276 to PROGENICS PHARMACEUTICALS INC for 721744.00 on 2025-07-01.

Files

File Type Posted
36F79725D0093 36C26025F0276_1.docx DOCX document
P03 JA 36C260-25-AP-1501.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors